⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MCRB News
Seres Therapeutics, Inc.
Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
globenewswire.com
MCRB
Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
globenewswire.com
MCRB
Seres Therapeutics to Present at CARB-X Investor Day
globenewswire.com
MCRB
Form 8-K
sec.gov
MCRB
Form 8-K
sec.gov
MCRB
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
globenewswire.com
MCRB
Form 8-K
sec.gov
MCRB
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
globenewswire.com
MCRB
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases
globenewswire.com
MCRB
Particles for Humanity Appoints Marcus Chapman as Senior Vice President and Head of Finance
prnewswire.com
MCRB